These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 6152826

  • 1. The effect of sulphydryl block on the binding of H1-antagonists to the muscarinic receptor.
    Burgen AS, Harbird CJ.
    Br J Pharmacol; 1983 Dec; 80(4):600-1. PubMed ID: 6152826
    [Abstract] [Full Text] [Related]

  • 2. The effect of p-chloromercuribenzoate on structure-binding relationships of muscarinic receptors in the rat cerebral cortex.
    Birdsall NJ, Burgen AS, Hulme EC, Wong EH.
    Br J Pharmacol; 1983 Sep; 80(1):197-204. PubMed ID: 6652370
    [Abstract] [Full Text] [Related]

  • 3. The effects of p-chloromercuribenzoate on muscarinic receptors in the cerebral cortex.
    Birdsall NJ, Burgen AS, Hulme EC, Wong EH.
    Br J Pharmacol; 1983 Sep; 80(1):187-96. PubMed ID: 6652369
    [Abstract] [Full Text] [Related]

  • 4. Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites.
    Hals PA, Hall H, Dahl SG.
    Life Sci; 1988 Sep; 43(5):405-12. PubMed ID: 2899826
    [Abstract] [Full Text] [Related]

  • 5. [Regeneration of functionally active rat brain muscarinic receptor in vitro after inhibition with methylmercury chloride].
    Wei M, Wu D, Liu X, Yang X.
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Jun; 28(2):140-4. PubMed ID: 10683921
    [Abstract] [Full Text] [Related]

  • 6. H1 antagonists: receptor affinity versus selectivity.
    Gillard M, Christophe B, Wels B, Peck M, Massingham R, Chatelain P.
    Inflamm Res; 2003 Apr; 52 Suppl 1():S49-50. PubMed ID: 12755407
    [No Abstract] [Full Text] [Related]

  • 7. Modification of adrenaline mydriasis by agents acting on sulphydryl groups.
    Tongia SK, Pandya K, Vijayvargiya R.
    Indian J Physiol Pharmacol; 1982 Apr; 26(1):94-6. PubMed ID: 7106968
    [No Abstract] [Full Text] [Related]

  • 8. The importance of thiol- and disulfide groups in agonist and antagonist binding to the muscarinic receptor.
    Hedlund B, Bartfai T.
    Mol Pharmacol; 1979 May; 15(3):531-44. PubMed ID: 492144
    [No Abstract] [Full Text] [Related]

  • 9. Differentiation of opiate agonist and antagonist receptor binding by protein modifying reagents.
    Wilson HA, Pasternak GW, Snyder SH.
    Nature; 1975 Feb 06; 253(5491):448-50. PubMed ID: 46111
    [No Abstract] [Full Text] [Related]

  • 10. Blockade of muscarinic, histamine H1 and histamine H2 receptors by antidepressants.
    Alvarez FJ, Velasco A, Palomares JL.
    Pharmacology; 1988 Feb 06; 37(4):225-31. PubMed ID: 3194442
    [Abstract] [Full Text] [Related]

  • 11. Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain.
    Aronstam RS, Abood LG, Hoss W.
    Mol Pharmacol; 1978 Jul 06; 14(4):575-86. PubMed ID: 683175
    [No Abstract] [Full Text] [Related]

  • 12. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
    Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G.
    J Med Chem; 2003 Feb 27; 46(5):856-67. PubMed ID: 12593665
    [Abstract] [Full Text] [Related]

  • 13. [The effect of antihistaminic preparations on the binding of labelled mepyramine, ketanserin and quinuclidinyl benzilate in the rat brain].
    Gankina EM, Porodenko NV, Kondratenko TI, Severin ES, Kaminka ME, Mashkovskiĭ MD.
    Eksp Klin Farmakol; 1993 Feb 27; 56(1):22-4. PubMed ID: 8100727
    [Abstract] [Full Text] [Related]

  • 14. Effects of p-chloromercuribenzoate on muscarinic receptor binding in rat brain [proceedings].
    Birdsall NJ, Burgen AS, Hulme EC, Wong EH.
    Br J Pharmacol; 1980 Jan 27; 68(1):142P-143P. PubMed ID: 7357157
    [No Abstract] [Full Text] [Related]

  • 15. Agonist binding to multiple muscarinic receptors.
    Vickroy TW, Watson M, Yamamura HI, Roeske WR.
    Fed Proc; 1984 Oct 27; 43(13):2785-90. PubMed ID: 6383872
    [Abstract] [Full Text] [Related]

  • 16. Piperidine-containing histamine H3-receptor antagonists of the carbamate series: variation of the spacer length.
    Łazewska D, Kieć-Kononowicz K, Pertz HH, Stark H, Schunack W, Elz S.
    Pharmazie; 2001 Dec 27; 56(12):927-32. PubMed ID: 11802653
    [Abstract] [Full Text] [Related]

  • 17. In vitro antagonism of benzodiazepine binding to cerebral receptors by H1 and H2 antihistamines.
    Speeg KV, Wang S, Avant GR, Parker R, Schenker S.
    J Lab Clin Med; 1981 Jan 27; 97(1):112-2. PubMed ID: 6108979
    [Abstract] [Full Text] [Related]

  • 18. Functional and binding studies with muscarinic M2-subtype selective antagonists.
    Lazareno S, Roberts FF.
    Br J Pharmacol; 1989 Sep 27; 98(1):309-17. PubMed ID: 2804551
    [Abstract] [Full Text] [Related]

  • 19. Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia.
    Moree WJ, Li BF, Jovic F, Coon T, Yu J, Gross RS, Tucci F, Marinkovic D, Zamani-Kord S, Malany S, Bradbury MJ, Hernandez LM, O'Brien Z, Wen J, Wang H, Hoare SR, Petroski RE, Sacaan A, Madan A, Crowe PD, Beaton G.
    J Med Chem; 2009 Sep 10; 52(17):5307-10. PubMed ID: 19663387
    [Abstract] [Full Text] [Related]

  • 20. Antimuscarinic and other receptor-blocking properties of antidepressants.
    Richelson E.
    Mayo Clin Proc; 1983 Jan 10; 58(1):40-6. PubMed ID: 6130192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.